Funding opportunities and news for global health researchers from the Fogarty International Center at the U.S. National Institutes of Health. On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Top NIH Funding News NIH funding news that may be relevant to global health researchers: Center for Global Health Fellowship Opportunities open to those with interest in cancer research and control in low- and middle-income countries (LMICs). Post-bachelor and post-doctoral fellowships are based in Rockville, Maryland, USA. Deadline: February 25, 2022 NIH Requests for Input Inviting Comments and Suggestions to Advance Research and Vaccine Development for Coccidioidomycosis (Valley Fever) (NOT-AI-22-026) Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility (NOT-OD-22-061) Upcoming Deadlines for Fogarty Funding Opportunities International Research Scientist Development Award (IRSDA) Application deadline: March 9, 2022 Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships in Japan (Extramural) Long-term Application deadline: March 31, 2022 Japan Society for the Promotion of Science Postdoctoral (JSPS) Fellowships in Japan (Extramural) - Short-term Application deadline: March 31, 2022 Chronic, Noncommunicable Diseases and Disorders Research Training Application deadline: July 13, 2022 Global Infectious Diseases (GID) Application deadline: August 3, 2022 Upcoming deadlines for all Fogarty funding opportunities NIH Funding Opportunities NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply: Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trials Not Allowed) (PAR-22-082) Application Receipt Date(s): Multiple dates, see announcement. Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trials Required) (PAR-22-112) Application Receipt Date(s): December 23, 2022 Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trials Optional) (PAR-22-113) Application Receipt Date(s): December 23, 2022 HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trials Not Allowed) (RFA-NS-22-018) Application Receipt Date(s): March 09, 2023 Other Funding News NIH Notices of Special Interest (NOSIs) related to opportunities on which Fogarty is a funding partner: Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences (NOT-OD-22-065) Expiration Date: April 1, 2022 Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship (NOT-OD-22-057) Expiration Date: April 8, 2022 NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers: Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes (NOT-CA-22-045) Expiration date: March 1, 2024 Notice of changes to funding opportunities that may be of interest to global health researchers: Notice of Correction for PAR-22-091, "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trials Optional)" (NOT-CA-22-049) Notice of Change to RFA-CA-22-001, "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trials Not Allowed)" (NOT-CA-22-050) Notice of Change to RFA-CA-22-003, "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trials Not Allowed)" (NOT-CA-22-051) Notice of Clarification of Eligibility Regarding Foreign Components for PAR-20-084, "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trials Optional)" (NOT-EB-22-004) Notices of intent to publish NIH funding opportunities on which Fogarty is a funding partner: Dissemination and Implementation Research in Health (R01 Clinical Trials Optional) (NOT-CA-22-042) Dissemination and Implementation Research in Health (R21 Clinical Trials Optional) (NOT-CA-22-043) Dissemination and Implementation Research in Health (R03 Clinical Trials Not Allowed) (NOT-CA-22-044) Notices of intent to publish NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trials Optional) (NOT-CA-22-031) General Notices that may be of interest to global health researchers: FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN) (NOT-FD-22-006) NIGMS Limitations on Clinical Trial Applications Submitted to the NIH Research Project Grant (Parent R01 Clinical Trials Required) (NOT-GM-22-027) Non-NIH funding opportunities that may be of interest to global health researchers: ElrhasResearch for Health in Humanitarian Crises (R2HC) program is accepting applications for research in response to current or anticipated health crises and for research to strengthen health systems. Funded by the UK Department for International Development (DFID), Wellcome Trust and the UK National Institute for Health Research (NIHR). Application deadline: March 15, 2022 | Featured Fogarty News and Information Q and A with Dr. Shannon N. Zenk, Director of the National Institute of Nursing Research Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria co-authored by Fogarty grantee Dr. Babafemi Taiwo Nature Communications, February 3, 2022 Podcast:Dr. Peter Kilmarx: Distrust in Public Health in America Is One of Those Wicked Problems Coronavirus Crisis Update podcast from the Center for Strategic & International Studies, February 2, 2022 View all Fogarty news View and subscribe to Fogarty's Global Health Matters e-newsletter Featured NIH News and Information NIAID Pandemic Preparedness Plan targets prototype and priority pathogens NIH media advisory, February 2, 2022 NIH COVID-19 Funding and News NIH COVID-19 funding opportunities NIH COVID-19 information for grant applicants and grant recipients COVID-19 news, funding and resources for global health researchers compiled by Fogarty |
Events Training and events for global health researchers: February 8, 2022: Fogarty Advisory Board Meeting (Virtual) Director Roger Glass will give an update and lead a discussion of current and planned Fogarty activities February 10, 2022: Financial Toxicity Following Cancer in Low- and Middle-income Countries (Virtual) Part of the Global Cancer Research and Control Seminar Series from the Center for Global Health at the National Cancer Institute (NCI) February 14, 2022: Committee on Use of Race, Ethnicity, and Ancestry as Population Descriptors in Genomics Research (Virtual) Hosted by the National Academies of Sciences, Engineering, and Medicine February 24, 2022: Learn How to Report Your NIH-funded Publications Using My Bibliography (Virtual) Hosted by NIHs National Center for Biotechnology Information (NCBI) February 24, 2022:Ghana Breast Cancer Epidemiology Symposium (Virtual) Sponsored by the National Cancer Institute, this symposium brings together experts, collaborators, and advocates to review the current landscape and identify gaps of breast cancer epidemiology in Ghana. More Information View all Fogarty funding opportunities Search all NIH funding opportunities and notices Subscribe to NIH Guide for Grants and Contracts weekly emails SUBSCRIBER SERVICES: Manage Preferences | Unsubscribe You are subscribed to receive Fogarty Funding Opportunities email updates [email protected]. The Fogarty International Center, the international component of the U.S. National Institutes of Health, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships. We encourage you to forward this to colleagues who may find it of interest. This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH National Institutes of Health Bethesda, MD 20892 (301) 496-2075 [email protected] | | |